CXCR6

Across TCGA pan-cancer cohorts, CXCR6 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated CXCR6 data layer compared with 25 for mass-spec protein and 1 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher CXCR6 Mutation is associated with better overall survival. In most high-consensus cancer types, elevated CXCR6 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC and BRCA are the cancer types where CXCR6 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	II,III,IV	1.000	0.320	.008	36	view →
BRCA	DFS	Median	All	0.657	0.903	.007	20	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

CXCR6–UCEC (OS)

Open the UCEC breakdown →